{"entity":{"id":"rejuv-recon-pelvic-exenteration","kind":"technology","name":"Recovery after pelvic exenteration","aka":[],"tldr":"Removing the pelvic organs together can cure a recurrence that nothing else will, at the cost of one or two stomas and a long recovery. About half of patients have a major complication within 90 days. Overall quality of life scores recover by six to twelve months in most published series, while sexual function, body image and distress do not, and there are no randomised trials of any of it.","summary":"Pelvic exenteration removes the rectum, the bladder and, in women, the reproductive organs, together with whatever else the tumour involves, sometimes including bone, major nerves and iliac vessels. It is offered for locally advanced or recurrent cancer of the rectum, cervix, vagina, vulva, bladder and some sarcomas, usually after radiotherapy has already been given.\n\nWhat the operation costs in the first three months. A Norwegian series of 55 patients treated for recurrent cervical cancer between 1995 and 2020 reported major complications of grade 3 or above within 90 days in 53 per cent, and a 4 per cent postoperative death rate. Five-year overall survival was 46 per cent and cancer-specific survival 52 per cent at a median 14 years of follow-up. An Australian series of 24 exenterations for cervical cancer reported Clavien-Dindo III to IV complications in 37.5 per cent, unplanned return to theatre in 25.0 per cent, a clear margin in 81 per cent of curative-intent operations, and median overall survival of 45.6 months.\n\nWhat the evidence on recovery actually is. A 2026 systematic review of quality of life after exenteration for gynaecological cancers identified 23 studies and 1,655 patients, of whom 746 contributed quality of life data. Its first finding is methodological and is the one to lead with: \"No randomised trials were identified\", 17 of the 23 studies carried a serious risk of bias, and the prospective and retrospective studies were equal in number. Within those limits the pattern was consistent. Global quality of life in the first six months varied, with two of nine studies reporting deterioration, three stability and four improvement; beyond six months most studies showed stabilisation or recovery. Domain-specific harm did not follow the same curve: sexual function deteriorated in 11 of 14 studies, body image worsened in 8 of 12 and was often associated with having a stoma, and psychological distress increased in every study that assessed it. Two stomas, resections below or through the levator muscles and adjuvant radiotherapy predicted worse outcomes, and vaginal reconstruction predicted better ones.\n\nPain years later. A telephone survey of 48 people up to 13 years after exenteration, using the Chronic Pain Grade Scale and the Short Form 12, found pain prevalence of 75 per cent, with most of those reporting no to low intensity pain without disability (54 per cent). Physical scores were significantly below population norms and mental scores were preserved.\n\nThe mismatch between the questionnaires and what people say. The Norwegian study interviewed ten long-term disease-free survivors a median nine years afterwards alongside the standard instruments, and found the two disagreed. The standardised measures showed generally preserved global and functional scores, while the interviews described persistent physical, practical and relational difficulty: the logistics of two stomas, fatigue and pain constraining daily life, and permanent loss of sexual function and altered body image. Nearly all of the participants still considered the surgery worthwhile. Both halves of that sentence belong in a consultation.\n\nNutrition before the operation. Nine retrospective cohorts of 1,057 patients found low body mass index associated with higher postoperative morbidity (odds ratio 1.12, 1.02 to 1.23), with hypoalbuminaemia and malnutrition by subjective global assessment trending the same way without reaching significance, and malnourished patients having longer stays and more reoperations. That is the argument for prehabilitation in this group, and it has not been tested here directly.\n\nWhat comes back, and when: walking, eating and ordinary activity come back over three to twelve months in most people. Stoma care, urinary diversion care and altered body image are permanent. Sexual function after exenteration is usually lost, and vaginal reconstruction improves but does not restore it.","status":"standard-of-care","asOf":"2026-10-02","wikipedia":"https://en.wikipedia.org/wiki/Pelvic_exenteration","links":[{"label":"Pelvic exenteration for cervical cancer: oncologic outcome and long-term health-related quality of life, a mixed methods study (Gynecol Oncol 2026)","url":"https://doi.org/10.1016/j.ygyno.2026.06.001"},{"label":"Quality of life outcomes following pelvic exenteration for gynaecological malignancies: a systematic review (Anticancer Res 2026)","url":"https://doi.org/10.21873/anticanres.18172"},{"label":"Patient experience after pelvic exenteration: chronic pain and quality of life (Support Care Cancer 2026)","url":"https://doi.org/10.1007/s00520-026-10848-y"},{"label":"Pelvic exenteration for cervical cancer: oncological, morbidity and quality of life outcomes (J Surg Oncol 2026)","url":"https://doi.org/10.1002/jso.70396"},{"label":"Impact of pre-operative nutritional status on postoperative outcomes following pelvic exenteration (ANZ J Surg 2026)","url":"https://doi.org/10.1111/ans.70896"}],"tags":["rejuvenation","survivorship","rehabilitation","evidence:moderate"],"related":[],"cancers":["cervical","colorectal","rectal-cancer","hpv-associated-vulvar-cancer","urothelial","anal"],"sections":["rejuvenation","surgery"],"technologies":["rejuv-recon-stoma-reversal","rejuv-rehab-pelvic-floor","rejuv-rehab-cancer-rehabilitation","rejuv-rehab-prehabilitation-evidence","sexual-function-after-cancer","bowel-after-pelvic-radiotherapy","oncology-nutrition"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["stoma","quality-of-life","late-effects"],"trials":[],"people":[],"bottlenecks":["b-survivorship","b-toxicity-qol"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"principle":"Exenteration trades organs for a clear margin. Everything in the recovery follows from which structures were taken: two stomas instead of one when both the bowel and the urinary tract go, pelvic floor and perineal wound problems when the resection goes below the levator muscles, and nerve loss when the sacral roots are divided. Those are structural losses, which is why global questionnaires recover and the domain-specific ones do not.","strengths":["Can achieve a clear margin and long survival where no other treatment can","Global quality of life stabilises or recovers beyond six months in most series","Vaginal reconstruction is associated with better reported outcomes"],"limitations":["No randomised trials exist, and most studies carry a serious risk of bias","Around half have a major complication within 90 days","Sexual function, body image and distress do not recover with the global scores"]},"route":"/technologies/rejuv-recon-pelvic-exenteration/","neighbours":{"cancer":[{"id":"anal","kind":"cancer","name":"Anal cancer (squamous cell carcinoma)","route":"/cancers/anal/"},{"id":"urothelial","kind":"cancer","name":"Bladder & urothelial cancer","route":"/cancers/urothelial/"},{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"},{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"hpv-associated-vulvar-cancer","kind":"cancer","name":"HPV-associated vulvar squamous cell carcinoma","route":"/cancers/hpv-associated-vulvar-cancer/"},{"id":"rectal-cancer","kind":"cancer","name":"Rectal cancer","route":"/cancers/rectal-cancer/"}],"section":[{"id":"rejuvenation","kind":"section","name":"Recovery & Rejuvenation","route":"/fronts/rejuvenation/"},{"id":"surgery","kind":"section","name":"Surgery & Interventional","route":"/fronts/surgery/"}],"technology":[{"id":"bowel-after-pelvic-radiotherapy","kind":"technology","name":"Bowel function after pelvic radiotherapy","route":"/technologies/bowel-after-pelvic-radiotherapy/"},{"id":"rejuv-rehab-cancer-rehabilitation","kind":"technology","name":"Cancer rehabilitation: the discipline that puts function back","route":"/technologies/rejuv-rehab-cancer-rehabilitation/"},{"id":"oncology-nutrition","kind":"technology","name":"Nutrition support and cachexia management","route":"/technologies/oncology-nutrition/"},{"id":"rejuv-rehab-pelvic-floor","kind":"technology","name":"Pelvic floor rehabilitation after prostate and rectal surgery and after pelvic radiotherapy","route":"/technologies/rejuv-rehab-pelvic-floor/"},{"id":"sexual-function-after-cancer","kind":"technology","name":"Sexual function and intimacy after cancer, for both sexes","route":"/technologies/sexual-function-after-cancer/"},{"id":"rejuv-recon-stoma-reversal","kind":"technology","name":"Stoma reversal after rectal cancer surgery: who gets the bowel joined up again","route":"/technologies/rejuv-recon-stoma-reversal/"},{"id":"rejuv-rehab-prehabilitation-evidence","kind":"technology","name":"What the randomised trials of prehabilitation found, operation by operation","route":"/technologies/rejuv-rehab-prehabilitation-evidence/"}],"term":[{"id":"late-effects","kind":"term","name":"Late effects and survivorship toxicity","route":"/terms/late-effects/"},{"id":"quality-of-life","kind":"term","name":"Quality of life","route":"/terms/quality-of-life/"},{"id":"stoma","kind":"term","name":"Stoma (colostomy, ileostomy, urostomy)","route":"/terms/stoma/"}],"bottleneck":[{"id":"b-survivorship","kind":"bottleneck","name":"Survivorship and late effects are neglected","route":"/bottlenecks/b-survivorship/"},{"id":"b-toxicity-qol","kind":"bottleneck","name":"Toxicity and quality of life are undervalued","route":"/bottlenecks/b-toxicity-qol/"}]}}